TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Benchmark Genetics Norway AS
Closing information (x1000 DKK)
| Closing information | 2023/09 | 2022/09 | 2021/09 |
| Turnover |
274,419
|
252,799
|
212,642 |
| Financial expenses |
3,931
|
4,143
|
3,744 |
| Earnings before taxes |
35,824
|
28,922
|
14,170 |
| Total assets |
213,011
|
231,725
|
238,778 |
| Current assets |
58,460
|
67,628
|
71,832 |
| Current liabilities |
65,856
|
58,025
|
41,657 |
| Equity capital |
103,416
|
81,078
|
59,860 |
| - share capital |
5,957
|
6,394
|
6,566 |
Financial ratios
| Fiscal year | 2023/09 | 2022/09 | 2021/09 |
| Solvency |
48.5%
|
35.0%
|
25.1% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
13.1%
|
11.4%
|
6.7% |
| Return on assets (ROA) |
18.7%
|
14.3%
|
7.5% |
| Current ratio |
88.8%
|
116.5%
|
172.4% |
| Return on equity (ROE) |
34.6%
|
35.7%
|
23.7% |
| Change turnover |
38,890
|
45,742
|
38,226 |
| Change turnover % |
17%
|
22%
|
22% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/09 | 2022/09 | 2021/09 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.